↓ Skip to main content

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Overview of attention for article published in Annals of the Rheumatic Diseases, November 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
17 news outlets
blogs
1 blog
twitter
150 tweeters

Citations

dimensions_citation
138 Dimensions

Readers on

mendeley
464 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Published in
Annals of the Rheumatic Diseases, November 2022
DOI 10.1136/ard-2022-223356
Pubmed ID
Authors

Josef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimme L Hyrich, Janet E Pope, Savia de Souza, Tanja A Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Theodora P M Vliet Vlieland, René Westhovens, Désirée van der Heijde, M. L. Marques, S. Ramiro, M. Van Lunteren, R. Stal, I. J. Berg, K. Minde Fagerli, M. Van Oosterhout, S. Exarchou, R. Ramonda, M. G. H. Van de Sande, R. B. M. Landewé, D. Van der Heijde, F. A. Van Gaalen

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 150 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 464 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
India 1 <1%
Unknown 462 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 89 19%
Other 51 11%
Researcher 42 9%
Student > Master 42 9%
Student > Ph. D. Student 34 7%
Other 95 20%
Unknown 111 24%
Readers by discipline Count As %
Medicine and Dentistry 134 29%
Unspecified 92 20%
Pharmacology, Toxicology and Pharmaceutical Science 29 6%
Biochemistry, Genetics and Molecular Biology 21 5%
Agricultural and Biological Sciences 12 3%
Other 53 11%
Unknown 123 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 222. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2023.
All research outputs
#163,824
of 24,518,979 outputs
Outputs from Annals of the Rheumatic Diseases
#64
of 7,644 outputs
Outputs of similar age
#4,685
of 432,830 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#7
of 44 outputs
Altmetric has tracked 24,518,979 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,644 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,830 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.